Cathy Eng

42PUBLICATIONS
210CO-AUTHORS
Social epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Aug 01, 2026
Early-Onset Gastric Cancer as a High-Risk Disease Entity in the United States: Clinicopathologic Features, Regional Variation, and Outcomes.

|May 08, 2026
Trends in primary surgery and overall survival in non-metastatic anal cancer: a population-based analysis.

|Apr 21, 2026
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Jan 07, 2026
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal.

Van K Morris, Kristen K Ciombor, Lianchun Xiao

|Aug 01, 2025
A blueprint for creating an early-onset colorectal cancer program based on experiences from 7 clinical centers across the United States and Canada.

Kimmie Ng, Cathy Eng, Petra Wildgoose

|Jul 03, 2025
Cancer in the Prime of Life: Etiologic Insights and Supportive Oncologic Interventions for the Rising Burden of Young Adult Cancer.

Christopher G Cann, Cathy Eng

Pageof 7

Frequent Collaborators

7 joint publications

Van Karlyle Morris

5 joint publications

Al B Benson

4 joint publications

Josep Tabernero

4 joint publications

Kristen K Ciombor